ASK THE HEMATOPATHOLOGISTS – Drs. Lynch and Foucar walk through their diagnostic approach to monocytosis. MINI REVIEW – Dr. David Garcia provides an update of ACCP Guidelines for the management of venous thromboembolism. PRESIDENT’S COLUMN – ASH President Dr. Charles Abrams reports on the ASH Executive Committee Spring retreat. PROGRAM GENEALOGIES – Dr. Rainer Storb chronicles the history of th...

The authors have reported to the ACCP that no significant conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article. Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal. org/misc/reprints.shtml). Correspondence to: Anna Fijalkowska, MD, National Resear...

The authors have reported to the ACCP that no significant conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article. Reproduction of this article is prohibited without written permission from the American College of Chest Physicians (www.chestjournal. org/site/misc/reprints.xhtml). Correspondence to: Charles L. Sprung, MD, FCCP, Had...

I was involved with Dr E. C. Rosenow III, then president of the American College of Chest Physicians (ACCP), in creating the honor of Master Clinician, which was bestowed on Dr Friedrich Wegener in Boston, Massachusetts, in October 1989. I believe it is understandable I would be concerned over the withdrawal of the honor 1 on the basis of unfounded and egregious charges made against Wegener in ...

Atrial fibrillation is the most common cardiac arrhythmia in adults. The prevalence of atrial fibrillation rises with age, reaching as high as 9% in those 70 years and older. Currently there are 2.2 million affected people in the United States, with twice the mortality rate of age-matched controls in sinus rhythm. Epidemiologic studies show atrial fibrillation to be responsible for as many as 1...

To the Editor: lot formation within a deep vein is called deep vein thrombosis (DVT). It occurs in about 100 persons per 100,000 population each year in the United States and leads to about 600,000 pulmonary thromboembolism (PTE) cases and also causes 60,000 deaths annually (1, 2). For many years, unfractionated heparin (UFH) and warfarin have been used for treatment of DVT and prevention of PT...

Abstract Background There is a growing body of evidence showing substantial underuse appropriate venous thromboembolism (VTE) prophylaxis in patients at risk. In the present study, our goal was to assess current practices use rate VTE among hospitalized Jordan and Lebanon. Methods A cross-sectional, multicenter, observational study conducted on 40 centers across Lebanon Jordan. We included who ...